{"F": {"ts_code": "US.NVS", "name": "诺华制药", "mkt": "US", "ccy": "美元", "sw1": "一般药品制造商", "sw2": "一般药品制造商", "sw3": "", "ind": "一般药品制造商", "fin_source": "futu", "market": "NYSE", "list_date": null, "is_fin": false, "roles": {"fin": false, "commodity": false, "precious": false, "regulated": false, "hard": false, "growth": false}, "province": null, "main_business": "", "introduction": "", "close": 159.99, "pe_ttm": 24.167, "pb": 7.32, "dv_ttm": 2.96, "total_mv": 30409536.72516, "trade_date": "20260904", "years": ["最近年报"], "multi_year": false, "period": "最近年报", "gm_series": [75.8], "rev_series": [566.7], "np_series": [139.7], "roe_series": [31.0], "rev_ttm": 566.7, "np_ttm": 127.6, "ocf_ttm": 183.9, "fcf_ttm": null, "fcf_yield": null, "ocf_yield": 6.0, "gm_median": 75.8, "gm_std": null, "gm_stab": null, "gm_chg_2022": null, "npm_median": 24.6, "roe_median": 31.0, "commodity": false, "hard_ratio": 11.0, "fix_assets": 117.6, "hard_note": "PP&E 毛额 × 0.5 近似净额", "goodwill_ratio": null, "pb_calc": null, "capex_dep": null, "interest_debt": null, "debt_ebitda": null, "ebitda": 228.2, "debt_ratio": 58.0, "debt_mv": null, "payout": 72.0, "div_years": 1, "rev_cagr3": null, "np_cagr3": null, "rev_yoy": 9.6, "np_yoy": 17.0, "np_vol": null, "loss_years": 0, "far_share": 79.0, "earn_yield": 4.1, "consensus_n": 0, "fwd_pe": null, "fwd_pe2": null, "fwd_g1": null, "fwd_g2": null, "peg": null, "consensus_disp": null, "mainbz": [], "ret_prev_year": null, "ret_prev2_year": null, "ret_pivot": null, "prev_year": "", "prev2_year": "", "ret_ytd": 19.6, "ret_20": 2.3, "ret_60": 8.0, "ret_120": 3.3, "ret_250": 28.1, "mdd_250": null, "vol_250": null, "pos_52w": 96.7, "eps": 7.15}, "S": {"duration": 45, "pricing": 70, "hard": 18, "bondness": 56}, "label": "定价权·品牌", "tags": ["轻资产现金牛"], "text": {"像什么": ["没有硬资产(固定资产占比 11%)但有定价权:毛利率最新年报 75.8%、ROE 最新年报 31.0%。", "经营现金流/市值 6.0%,分红率 72%,分子跟得上通胀。"], "为什么(不)算钱的替代品": "只占定价权一条(毛利率 75.8%),硬资产占比 11%。分子能跟上通胀,但没有重置成本对冲;按'定价权·品牌'看,不按硬资产看。", "加息期怎么走": "分子跟得上通胀、久期不长,加息期抗跌;放水期弹性不如科技。属船票一侧的'非债券'部分。", "四问": [["当前 FCF 能覆盖多少市值?", "经营现金流/市值 6.0%(futu 无资本开支,FCF 按经营现金流 × 0.7 近似)。一般。"], ["能否每年提价而不掉量?", "毛利率最新年报 75.8%。能。"], ["资产重置成本随通胀涨吗?", "固定资产占总资产 11%。没有资产可言。"], ["估值里多少来自 5 年后的故事?", "按 PE 24.2 倍 粗算,约 79%(1 − 5/PE)。>70%,把 5 年后的假设砍一半,这个股票值多少钱?"]], "价格行为": "近一年 28%,现价在 52 周高点的 97%;近 20 / 60 / 120 日 2% / 8% / 3%。", "行业对照": ["同富途行业「一般药品制造商」21 家中位:PE 24.4 / 股息率 2.1% / 毛利率 72.2% / 固定资产占比 10% / 分红率 56%。", "诺华制药:PE 比行业中位低 0.2倍;股息率 比行业中位高 0.9个百分点;毛利率 比行业中位高 3.6个百分点;固定资产占比 比行业中位高 0.7个百分点。"]}}